Clark Ian T
CIK 0001336504
Director
Filings
29
Latest Jun 4, 2026
Issuers covered
8
Showing
29 of 29
Page 1
Track record
9 of 10 open-market trades scored (90% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 78% | -1.9% | +0.1% | +4.5% | -17.5% |
| 90 days | 9 | 67% | +6.4% | +9.3% | +46.4% | -49.3% |
| 180 days | 6 | 0% | -43.5% | -32.3% | -24.5% | -107.3% |
| 365 days | 2 | 0% | -229.1% | -229.1% | -229.1% | -229.1% |
Issuers
Companies where Clark Ian T has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GH | Guardant Health, Inc. | 8 | May 22, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | 6 | Dec 23, 2025 |
| CRVS | Corvus Pharmaceuticals, Inc. | 5 | Jun 16, 2025 |
| GDRX | Goodrx Holdings, Inc. | 3 | Jul 9, 2025 |
| AVRO | Avrobio, Inc. | 2 | Jun 8, 2023 |
| BMRN | Biomarin Pharmaceutical Inc | 2 | Jun 4, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | 2 | May 29, 2026 |
| AGIO | Agios Pharmaceuticals, Inc. | 1 | May 24, 2022 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|